Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest

Tekmira Pharma (NASDAQ:TKMR) +4.2% AH following a Daily Mail story suggesting it is a takeover candidate, after shares have nearly doubled in the past month thanks to attention over its experimental treatment for the deadly ebola virus.

Rumors suggest interested parties could include Shire (NASDAQ:SHPG) and GlaxoSmithKline (NYSE:GSK); the report suggests the recent premium paid forĀ  InterMune could put a valuation of at least $40/share on TKMR.

From other sites
Comments (10)
  • john812
    , contributor
    Comments (42) | Send Message
    I will take that.
    27 Aug 2014, 07:05 PM Reply Like
  • RecklessAbandon
    , contributor
    Comments (37) | Send Message
    The daily mail said the same thing about $ARIA couple of months ago :)
    27 Aug 2014, 07:12 PM Reply Like
  • BioDoubt
    , contributor
    Comments (19) | Send Message
    And countless others as well. They are always wrong, but yet retail traders bid it up every single time.
    27 Aug 2014, 07:48 PM Reply Like
  • flyerguy1300
    , contributor
    Comments (861) | Send Message
    I'll take the takeover more profit for me :)
    27 Aug 2014, 07:41 PM Reply Like
  • Amerc96
    , contributor
    Comments (9) | Send Message
    Statistically, shorting into the teeth of these kind of rumors has been a winning play......just sayin....
    27 Aug 2014, 07:42 PM Reply Like
  • shakazoid
    , contributor
    Comments (244) | Send Message
    A new sucker is born everyday for Daily mail. It is the Fox news of M&A
    27 Aug 2014, 07:56 PM Reply Like
  • temac
    , contributor
    Comment (1) | Send Message
    Temack50, I truly enjoyed the write up i'm long tkmr and believe in their progress. I currently work in molecular, anti-body and peptide imaging for diagnostic and therapeutic treatments i hope they succeed.
    27 Aug 2014, 09:05 PM Reply Like
  • patfactorx
    , contributor
    Comments (126) | Send Message
    Fast money is fast money
    28 Aug 2014, 01:03 AM Reply Like
  • great article
    , contributor
    Comments (3) | Send Message
    As long as ebola continues to claim lives, TKMR will continue to surge. It's likely to see $32 short term before it's said and done, and unless there is a buyout as rumored.
    30 Aug 2014, 08:57 AM Reply Like
  • Amerc96
    , contributor
    Comments (9) | Send Message
    Good call.....hahahah
    7 Aug 2015, 07:52 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs